Program Goals DLBCL Subtypes 2008 WHO Classification Other DLBCL Variants Dissecting DLBCL into Molecularly and Clinically Distinct Subgroups by Gene Expression Profiling Outcomes Based on DLBCL Subtype Using Gene Expression Profiling ID: 774803
Download Presentation The PPT/PDF document " Updates in Diffuse Large B-Cell Lymphom..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Updates in Diffuse Large B-Cell Lymphoma
Slide2Program Goals
Slide3DLBCL Subtypes 2008 WHO Classification
Slide4Other DLBCL Variants
Slide5Dissecting DLBCL into Molecularly and Clinically Distinct Subgroups by Gene Expression Profiling
Slide6Outcomes Based on DLBCL Subtype Using Gene Expression Profiling
Slide7Efficacy of Bortezomib in Combination With Chemotherapy in DLBCL Subtypes
Slide8Efficacy of R2CHOP in Newly-Diagnosed DLBCL Subtypes
Slide9Ibrutinib In Relapsed/Refractory DLBCL
Slide10Possible Methods to Improve Outcomes in DLBCL
Slide11Treatment-Related Deaths and Prephase Therapy in Elderly DLBCL Patients
Slide12Adjuvant Radiotherapy After CHOP-R For Patients With Bulky Disease
Slide13Deauville Criteria
Slide14Using PET/CT to Predict Outcomes in Patients With PMLBCL
Slide15Response-Adapted Therapy
Slide16Interim PET-Directed Therapy in Advanced DLBCL
Slide17Chemotherapy Plus Autotransplantation in Patients With Aggressive Lymphoma
Slide18Dose-intense Chemotherapy + Autotransplantation in Primary Therapy of Patients With Aggressive Lymphoma
Slide19ASCT Shows Benefit in High-Risk Aggressive Lymphoma
Slide20RICOVER-60 and SMARTE-R TrialsPharmacogenomics of Rituximab in Lymphoma
Slide21SEXIE-R-CHOP-14Increased Dose of Rituximab In Elderly Males
Slide22Characteristics of Double-Hit DLBCL
Slide23Approach To Patients With DLBCL
Slide24Concluding Remarks
Slide25Abbreviations
Slide26Abbreviations (cont)
Slide27Abbreviations (cont)
Slide28References
Slide29References (cont)
Slide30References (cont)
Slide31References (cont)
Slide32References (cont)
Slide33References (cont)
Slide34References (cont)
Slide35References (cont)